|
1
|
Yung KW, Yung TT, Chung CY, Tong GT, Liu
Y, Henderson J, Welbeck D and Oseni S: Principles of cancer
staging. Asian Pac J Surg Oncol. 1:1–16. 2015.
|
|
2
|
Nozaki T, Iida H, Morii A, Fujiuchi Y,
Komiya A and Fuse H: Use of the laparoscope holder for liver
retraction during urological laparoscopic surgery. Curr Urol.
6:99–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamai T, Furuya N, Kambara T, Abe H, Honda
M, Shioyama Y, Kaji Y and Yoshida K: Single minimum incision
endoscopic radical nephrectomy for renal tumors with preoperative
virtual navigation using 3D-CT volume-rendering. BMC Urol.
10:72010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jun HY, Ryu JH, Byun SJ, Jeong CW, Kim TH,
Lee YH and Yoon KH: Combined radiofrequency ablation and double
anti-angiogenic protein therapy to increase coagulation efficacy:
An experimental study in a murine renal carcinoma model. Korean J
Radiol. 16:776–782. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Modabber M, Martin J and Athreya S:
Thermal versus impedance-based ablation of renal cell carcinoma: A
meta-analysis. Cardiovasc Intervent Radiol. 37:176–185. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kroeze SG, van Melick HH, Nijkamp MW,
Kruse FK, Kruijssen LW, van Diest PJ, Bosch JL and Jans JJ:
Incomplete thermal ablation stimulates proliferation of residual
renal carcinoma cells in a translational murine model. BJU Int.
110:(6 Pt B). E281–E286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chan AA, Ahrar K and Matin SF: Ablative
therapies in renal cell carcinoma. Minerva Urol Nefrol. 63:237–250.
2011.PubMed/NCBI
|
|
8
|
Kong WT, Zhang WW, Guo HQ, Qiu JL, Tang M,
Jiang ZM, Shen Y, Li XG and Zhang SW: Application of
contrast-enhanced ultrasonography after radiofrequency ablation for
renal cell carcinoma: Is it sufficient for assessment of
therapeutic response? Abdom Imaging. 36:342–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prokhorov DG, Shkol'nik MI, Shumskiĭ IA
and Belov AD: Application of radiofrequency ablation for treatment
of localized renal carcinoma. Vopr Onkol. 54:507–511. 2008.(In
Russian). PubMed/NCBI
|
|
10
|
Cahill T, Chen XL, Lee JW, Weiss M, Chang
VT and Cella D: Principles of radiofrequency ablation for cancer.
Asian Pac J Surg Oncol. 1:47–58. 2015.
|
|
11
|
Ramirez D, Akca O, Delluc A, Reaume N,
Haddock P and Chen XL: Staging of renal cell carcinoma. Asian Pac J
Surg Oncol. 2:281–290. 2016.
|
|
12
|
Powles T, Zhao S, Gorbonos A and Kapoor A:
Treatment strategies for renal cell carcinoma. Asian Pac J Surg
Oncol. 2:301–316. 2016.
|
|
13
|
Chang X, Liu T, Lin Y, Yu J and Liang P:
Radiofrequency ablation for renal cell carcinoma. Asian Pac J Surg
Oncol. 2:351–360. 2016.
|
|
14
|
Wendler JJ, Friebe B, Baumunk D, Blana A,
Franiel T, Ganzer R, Hadaschik B, Henkel T, Köhrmann KU, Köllermann
J, et al: Focal therapy for small renal masses: Observation,
ablation or surgery. Urologe A. 55:594–606. 2016.(In Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Reichle A, Grassinger J, Bross K, Wilke J,
Suedhoff T, Walter B, Wieland WF, Berand A and Andreesen R:
C-reactive Protein in patients with metastatic clear cell renal
carcinoma: An important biomarker for tumor-associated
inflammation. Biomark Insights. 1:87–98. 2007.PubMed/NCBI
|
|
16
|
Yang L, Wu X, Wang D, Luo C and Chen L:
Renal carcinoma cell-derived exosomes induce human immortalized
line of Jurkat T lymphocyte apoptosis in vitro. Urol Int.
91:363–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Figel AM, Brech D, Prinz PU, Lettenmeyer
UK, Eckl J, Turqueti-Neves A, Mysliwietz J, Anz D, Rieth N,
Muenchmeier N, et al: Human renal cell carcinoma induces a
dendritic cell subset that uses T-cell crosstalk for
tumor-permissive milieu alterations. Am J Pathol. 179:436–451.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Granov AM, Molchanov OE, Karelin MI,
Shkol'nik MI and Krotova OA: Influence of immunological parameters
on the effectiveness of systemic and loco-regional immunotherapy in
disseminated renal carcinoma. Vopr Onkol. 55:580–585. 2009.(In
Russian). PubMed/NCBI
|
